Pular para o conteúdo principal
Ranking Invest

FMS - Fresenius Medical Care AG & Co. KGaA

Segmento: HealthcareFresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Análise Ranking Invest

Valuation estimado
$ 14.80 Bi
Valor de Mercado
$ 11.90 Bi
Desconto (AV)-19.6%
IVR
1.24A companhia vale 1,24 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.21O valuation alternativo equivale a 21% do valor de mercado da companhia.
MLL
0.21O lucro líquido dos controladores em 16 trimestres equivale a 21% do valor de mercado.
Último Balanço Atualizado: 1T2025

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 13.24 Bi

Dívida Líquida

$ 9.75 Bi

L4T

$ 618.16 Mi

MM4T

3.20%

Indicadores Básicos

ROE

4.67%

Índices de Previsibilidade

Receita Líquida

B0.03

Lucro

B0.25

Margem

B0.25

Índices de Tendência

Receita Líquida

C7.29

Lucro

F-7.62

Margem

G-8.16

Índices de Endividamento

DIV/PAT

0.74

DIV/L4T

15.77

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.